Partnership Opportunities

The 2nd Annual Adenosine-Pathway Targeted Cancer Immunotherapy Summit unites a highly focused community of experts working to support the collective mission of supercharging adenosine-pathway therapies to patients in need.

How can your service assist in overcoming major obstacles in the field of immuno-oncology and advancing cancer immunotherapies that are specifically aimed at the adenosine pathway to the clinic?

Our audience is seeking partners of various types:

Pharmaceutical & Biotech

9 out of 10 trials at phase 2 and 3 have required a partnership with a larger pharmaceutical company to make them a reality. There are 26 phase 1 trials underway and 80+ preclinical candidates in play. Showing there is a rich stockpile of potential investment opportunities.

As a biotech, this unique community offers the perfect opportunity to set your pipeline’s value apart from the rest and gain exposure to find a partner to help your company reach the next level.

For pharma seeking to offer their expertise and technology, get center stage in front of the decision-makers at these fast-moving, high-potential biotechs.

Immunotherapy Solution Providers & Vendors

This is a space that is significantly underserved despite over 107 candidates in play with over 30% at the clinical stage. Get in on the ground floor of a field with high growth potential and establish yourselves as the leading service provider/vendor.

Don’t miss your chance to be part of the immunotherapy revolution that is treating 10+ previously hard-to-treat solid tumors, get into the center of the action as it unfolds.

Core products and services being sought after include tumor models, immunoassaysdiagnostics/biomarkers, and CROs.

By Collaborating with us, whether this is through speaking on the agenda, hosting networking sessions, or exhibiting, you'll company will have a unique opportunity to take advantage of market opportunities early, a position as a market leader, and meet your 2024 business objectives.

Why Partner With Us?

1

Benefit from
Market
Intelligence

Address the field’s current unmet needs and hear how and where pharmaceutical giants are looking for services and solutions to facilitate their R&D platforms

2

Meet & Network with Industry Pioneers

Meet prospective clients during structured networking breaks, bespoke 1-2-1 meetings, panel discussions & more

3

Position Yourself as an Industry Expert

Showcase your independent expertise in front of the key decision-makers in the field including biotech companies focused on developing adenosine inhibitors, large pharma and investors

4

Raise your Brand Awareness

Benefit from post-conference exposure to our KOL community and increase market share through unique branding formats

5

Generate Commercial Collaborations

Ensure your hottest prospects are in the room and part of the discussion by having a wish-list of your choice contacted in advance of the event

Who Will You Meet?

Adenosine Pathway Targeted Cancer Immunotherapy Summit brochure Asset 2
Adenosine Pathway Targeted Cancer Immunotherapy Summit brochure Asset 3